VIVO BIO TECH LTD. - 511509 - Un-Audited Standalone And Consolidated Financial Results For The Quarter Ended June 30, 2023
Vivo Bio Tech Limited has submitted with the exchange the Un-Audited Standalone & Consolidated Financial Results for the quarter ended June 30, 2023 VIVO BIO TECH LTD. - 511509 - Board Meeting Outcome for Approval Of Un-Audited Standalone & Consolidated Financial Statements Of The Company For The Quarter Ended June 30, 2023
Vivo Bio Tech Limited has submitted with the exchange the outcome of Board Meeting held on August 07, 2023 for Approval of Un-Audited Standalone & Consolidated Financial Statements Of The Company For The Quarter Ended June 30, 2023 VIVO BIO TECH LTD. - 511509 - Board Meeting Intimation for Approval Of Un-Audited Standalone And Consolidated Financial Results For The Quarter Ended June 30, 2023
VIVO BIO TECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2023 ,inter alia, to consider and approve Un-Audited Standalone and Consolidated Financial Results for the quarter ended June 30, 2023 VIVO BIO TECH LTD. - 511509 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Vivo Bio Tech Limited has submitted with the exchange the certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the period from 01.04.2023 to 30.06.2023. VIVO BIO TECH LTD. - 511509 - Closure of Trading Window
Vivo Bio Tech Limited has informed the exchange that the Trading Window of the Company will be closed for all insiders including designated persons and their immediate relatives from July 01, 2023 till 48 hours after the declaration of Un-Audited Financial Results of the Company for the quarter ended June 30, 2023. VIVO BIO TECH LTD. - 511509 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Vivo Bio Tech Limited has submitted with the exchange the copies of advertisement issued in newspapers on June 01, 2023, in 'Financial Express' in English Language and in 'Nava Telangana' in Telugu Language, with respect to the Audited Financial Results of the Company for the fourth quarter and year ended March 31, 2023. VIVO BIO TECH LTD. - 511509 - Related Party Transactions For The Half-Year Ended March 31, 2023
Vivo Bio Tech Limited has submitted with the exchange Related Party Transactions for the half-year period from 01.10.2022 to 31.03.2023 VIVO BIO TECH LTD. - 511509 - Audited Standalone And Consolidated Financial Statements For The Fourth Quarter And Year Ended March 31, 2023
Vivo Bio Tech Limited has submitted with the exchange the Audited Standalone & Consolidated Financial Statements of the Company for the fourth quarter and year ended March 31, 2023. VIVO BIO TECH LTD. - 511509 - Board Meeting Outcome for Board Meeting Outcome For Audited Standalone & Consolidated Financial Statements Of The Company For The Fourth Quarter And Year Ended March 31, 2023
Vivo Bio Tech Limited has submitted with the exchange the Outcome of Board meeting for the item transacted for approval of Audited Standalone & Consolidated Financial Statements of the Company for the fourth quarter and year ended March 31, 2023.